NeoGenomics Laboratories, Inc. Income Statement
NEO / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Revenue has grown at a 6.0% compound annual rate over the past 6 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | $61.7M | $244.1M | $5.0M | $5.0M | $5.0M | $5.0M | $43.5M |
| Cost of Revenue | $413.0M | $370.5M | $347.0M | $321.8M | $297.3M | $258.6M | $212.0M | $149.5M | $138.3M | $133.7M | - | - | - | - | - |
| Gross Profit | $314.3M | $290.1M | $244.6M | $187.9M | $187.1M | $185.9M | $196.8M | $127.3M | $102.0M | $98.1M | $43.8M | $26.8M | $19.4M | $19.4M | $19.4M |
| SG&A Expense | $273.3M | $259.7M | $243.1M | $243.4M | $221.3M | $143.8M | $128.0M | $84.8M | $70.4M | $63.9M | $33.6M | $15.8M | $12.3M | $12.3M | $12.3M |
| R&D Expense | $37.1M | $31.2M | $27.3M | $30.3M | $21.9M | $8.2M | $8.5M | $3.0M | $3.6M | $4.6M | $4.2M | $2.3M | $543.0K | $543.0K | $543.0K |
| Operating Income | -$115.9M | -$92.1M | -$107.7M | -$157.6M | -$118.8M | -$14.0M | $13.0M | $10.0M | $2.9M | $2.2M | -$5.6M | $1.2M | -$409.0K | -$409.0K | -$409.0K |
| Interest Expense | - | - | $6.9M | $7.6M | $8.2M | $7.0M | $3.7M | $6.2M | $5.5M | - | $854.0K | - | $768.0K | $768.0K | $768.0K |
| Income Tax | -$2.2M | -$1.9M | -$9.1M | -$15.1M | -$6.7M | -$18.2M | -$4.4M | $1.2M | -$2.3M | -$1.7M | -$2.0M | $0 | $152.0K | $0 | $0 |
| Net Income | -$108.0M | -$78.7M | -$88.0M | -$144.3M | -$8.3M | $4.2M | $8.0M | $2.6M | -$396.0K | -$6.1M | -$2.5M | $65.0K | -$1.2M | -$1.2M | -$1.2M |
| EPS (Basic) | - | - | - | - | - | - | - | - | - | - | $0.04 | $0.00 | -$0.03 | -$0.03 | - |
| EPS (Diluted) | - | - | - | - | - | - | - | - | - | - | $0.04 | $0.00 | -$0.03 | -$0.03 | -$0.09 |
| Shares Outstanding | 128.1M | 126.7M | 125.5M | 124.2M | 120.0M | 111.8M | 103.6M | 91.6M | 78.6M | 75.8M | 60.2M | 49.1M | 45.3M | 43.4M | 37.4M |
| Gross Margin | - | - | - | - | - | - | - | - | 165.3% | 40.2% | 875.1% | 536.7% | 388.6% | 388.6% | 44.7% |
| Operating Margin | - | - | - | - | - | - | - | - | 4.7% | 0.9% | -112.7% | 24.2% | -8.2% | -8.2% | -0.9% |
| Profit Margin | - | - | - | - | - | - | - | - | -0.6% | -2.5% | -50.7% | 1.3% | -23.5% | -23.5% | -2.7% |